Donald E. Bobo Jr - May 3, 2024 Form 4 Insider Report for Edwards Lifesciences Corp (EW)

Role
CVP,Strategy/Corp Development
Signature
Linda J. Park, Attorney-in-Fact
Stock symbol
EW
Transactions as of
May 3, 2024
Transactions value $
-$336,987
Form type
4
Date filed
5/6/2024, 07:16 PM
Previous filing
Apr 8, 2024
Next filing
May 9, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction EW Common Stock Tax liability -$40.7K -479 -1.2% $85.06 39.3K May 3, 2024 Direct
transaction EW Common Stock Options Exercise $0 +5.86K +14.9% $0.00 45.1K May 4, 2024 Direct F1
transaction EW Common Stock Tax liability -$296K -3.48K -7.7% $85.25 41.7K May 4, 2024 Direct
holding EW Common Stock 38.6K May 3, 2024 401(k) F2
holding EW Common Stock 135K May 3, 2024 By Trust

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction EW Performance Rights Options Exercise $0 -5.86K -100% $0.00* 0 May 4, 2024 Common Stock 5.86K Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On May 4, 2021, the Reporting Person was granted a target number of shares covered by restricted stock units with performance-based vesting requirements over a three-year performance period. On May 1, 2024, the Compensation and Governance Committee of the Board of Directors determined that 117.11% of the target number of shares would vest as of May 4, 2024, and the actual number of shares vested are reflected on this Form 4.
F2 Reflects shares represented on the most recent statement of the Issuer's 401(k) Plan Administrator.

Remarks:

This Form 4 reflects changes in beneficial ownership only; it does not identify other securities of the Issuer beneficially owned by the Reporting Person.